E-LIB Suche - Ergebnisse für: Alentorn, A.

1

Prognosis of glioblastoma patients improves significantly o..:

Thomas-Joulié, A. ; Tran, S. ; El Houari, L....
European Journal of Cancer. 202 (2024) - p. 114004 , 2024

Link: https://doi.org/10.1016/..

2

Recent advances in the diagnosis and the treatment of prima..:

Rachdi, A. ; Hernandez-Tost, H. ; Herzi, D....
Revue Neurologique. 179 (2023) 5 - p. 481-489 , 2023

Link: https://doi.org/10.1016/..

3

P13.12.A SUBTYPES AND SURVIVAL ANALYSIS ANALYSIS OF PRIMARY..:

BARILLOT, N ; HERNANDEZ, I ; KIRASIC, E...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii103-ii103 , 2023

Link: https://doi.org/10.1093/..

4

P14.08.A PROGNOSTIC VALUE OF CSF IL-10 AT THE 2-MONTH ASSES..:

Herzi, D ; Le Garff-Tavernier, M ; Sourdeau, E...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii107-ii107 , 2023

Link: https://doi.org/10.1093/..

5

Prediction of response to immune checkpoint blockade in pat..:

Ratovomanana, T. ; Nicolle, R. ; Cohen, R....
Annals of Oncology. 34 (2023) 8 - p. 703-713 , 2023

Link: https://doi.org/10.1016/..

6

CSF biomarkers in primary CNS lymphoma:

Nguyen-Them, L. ; Alentorn, A. ; Ahle, G....
Revue Neurologique. 179 (2023) 3 - p. 141-149 , 2023

Link: https://doi.org/10.1016/..

7

A "sixteen" syndrome due to lymphomatous infiltration of th..:

Thomas, A. ; Nilles, C. ; Alentorn, A.
Revue Neurologique. 176 (2020) 7-8 - p. 635-636 , 2020

Link: https://doi.org/10.1016/..

8

PL1.1 CDKN2A homozygous deletion is a strong adverse progno..:

Appay, R ; Dehais, C ; Colin, C...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii1-iii1 , 2019

Link: https://doi.org/10.1093/..

9

OS4.3 Feasibility and benefit of Molecular Profiling to Gui..:

Baldini, C ; Younan, N ; Castanon Alvarez, E...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii10-iii10 , 2019

Link: https://doi.org/10.1093/..

10

OS9.2 Radiomics analysis of lower-grade gliomas, a POLA Net..:

Younan, N ; Douzane, H ; Duran-Pena, A...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii18-iii18 , 2019

Link: https://doi.org/10.1093/..

11

OS9.3 Clinical, molecular and radiomic profile of gliomas w..:

Picca, A ; Alentorn, A ; Saragoussi, E...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii18-iii19 , 2019

Link: https://doi.org/10.1093/..

12

OS9.7 Telomere length, TERTp mutation and ALT status in adu..:

Birzu, C ; Hillairet, A ; Giry, M...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii19-iii20 , 2019

Link: https://doi.org/10.1093/..

13

P14.102 Cerebellar atrophy patterns in paraneoplastic cereb..:

Vialatte de Pémille, C ; Psimaras, D ; Adanyegu, I...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii92-iii92 , 2019

Link: https://doi.org/10.1093/..

14

JS1.1 Specific genetic alterations of breast tumors lead to..:

Desestret, V ; Pissaloux, D ; Treilleux, I...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii4-iii4 , 2019

Link: https://doi.org/10.1093/..

15

P01.148Intra-tumor heterogeneity analysis of low-grade glio..:

Alentorn, A ; Labreche, K ; Dehais, C...
Neuro-Oncology. 20 (2018) suppl_3 - p. iii266-iii266 , 2018

Link: https://doi.org/10.1093/..